25.90
Precedente Chiudi:
$26.67
Aprire:
$26.64
Volume 24 ore:
128.46K
Relative Volume:
0.42
Capitalizzazione di mercato:
$1.16B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.92%
1M Prestazione:
-8.50%
6M Prestazione:
+90.91%
1 anno Prestazione:
+40.53%
Septerna Inc Stock (SEPN) Company Profile
Nome
Septerna Inc
Settore
Industria
Telefono
650-338-3533
Indirizzo
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Confronta SEPN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
SEPN
Septerna Inc
|
25.84 | 1.19B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.14 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.58 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
818.35 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.51 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
341.10 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-19 | Iniziato | Raymond James | Strong Buy |
| 2025-12-15 | Iniziato | Truist | Buy |
| 2025-11-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-06-23 | Iniziato | H.C. Wainwright | Buy |
| 2025-02-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-19 | Iniziato | JP Morgan | Overweight |
| 2024-11-19 | Iniziato | TD Cowen | Buy |
| 2024-11-19 | Iniziato | Wells Fargo | Overweight |
Mostra tutto
Septerna Inc Borsa (SEPN) Ultime notizie
HC Wainwright Analysts Lower Earnings Estimates for Septerna - Defense World
HC Wainwright Issues Negative Forecast for Septerna Earnings - MarketBeat
Is Septerna (SEPN) Quietly Building an IP Moat with Its New Chief Legal Officer Hire? - simplywall.st
SEPN: HC Wainwright & Co. Updates Price Target to $35 | SEPN Sto - GuruFocus
Septerna stock price target raised to $35 from $30 at H.C. Wainwright - Investing.com Canada
The Analyst Verdict: Septerna In The Eyes Of 6 Experts - Benzinga
Septerna: Advancing GPCR Pipeline and De-Risked Valuation Support Upgraded Buy Rating and $35 Target - TipRanks
Aug Reactions: Does Septerna Inc have a sustainable dividendInflation Watch & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Septerna (NASDAQ:SEPN) Shares Up 7.5%Still a Buy? - MarketBeat
Septerna to Present GPCR Pipeline Updates at JPM Conference - TipRanks
Septerna, Inc. Announces Key Developments at J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Assessing Septerna (SEPN) Valuation After Recent Share Price Pullback And One Year 40.63% Return - Yahoo Finance
Septerna (NASDAQ:SEPN) Downgraded to “Buy” Rating by Wall Street Zen - Defense World
Septerna, Inc. (SEPN) Stock Analysis: Unraveling a 28.76% Potential Upside in Biotechnology - DirectorsTalk Interviews
Septerna, Inc. (NASDAQ:SEPN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Septerna Appoints Mark Wilson as Chief Legal Officer - The Globe and Mail
Will Septerna Inc. stock benefit from sector rotationMarket Growth Summary & AI Enhanced Market Trend Forecasts - Улправда
Why retail investors favor Septerna Inc. stockEarnings Risk Summary & Low Drawdown Trading Techniques - Улправда
What Wall Street predicts for Septerna Inc. stock priceMarket Growth Summary & Intraday High Probability Setup Alerts - ulpravda.ru
Septerna appoints Mark Wilson as chief legal officer By Investing.com - Investing.com South Africa
Septerna appoints Mark Wilson as chief legal officer - Investing.com
Septerna, Inc. Expands Leadership with New Chief Legal Officer - TradingView — Track All Markets
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer - The Manila Times
Septerna (NASDAQ:SEPN) Stock Price Down 6.3%What's Next? - MarketBeat
What analysts say about Septerna Inc stockDividend Yield Trends & AI-Based Predictions Available Free - earlytimes.in
Jones Trading initiates coverage of Septerna (SEPN) with buy recommendation - MSN
Jones Trading Initiates Coverage of Septerna (SEPN) with Buy Recommendation - Nasdaq
Septerna stock initiated with Buy rating at Jones Trading on GPCR pipeline By Investing.com - Investing.com South Africa
Septerna stock initiated with Buy rating at Jones Trading on GPCR pipeline - Investing.com Nigeria
Septerna (NASDAQ:SEPN) Coverage Initiated at Jones Trading - MarketBeat
Septerna (SEPN): Valuation Check After Raymond James Buy Rating and S&P Pharma Index Inclusion - Sahm
Septerna, Inc.(NasdaqGM: SEPN) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Septerna, Inc.(NasdaqGM: SEPN) added to NASDAQ Biotechnology Index - marketscreener.com
Septerna’s SEP-631 Study: A Potential Game-Changer in Pharmaceutical Research - MSN
Is New Coverage of Septerna (SEPN) Quietly Reframing Its GPCR Platform’s Risk‑Reward Profile? - simplywall.st
Septerna (NASDAQ:SEPN) Coverage Initiated at Raymond James Financial - Defense World
Septerna (NASDAQ:SEPN) Raised to "Strong-Buy" at Raymond James Financial - MarketBeat
Wall Street Zen Upgrades Septerna (NASDAQ:SEPN) to "Strong-Buy" - MarketBeat
Wall Street Zen Upgrades Septerna (NASDAQ:SEPN) to “Strong-Buy” - Defense World
Why Septerna Inc. stock could be next big winner2025 AllTime Highs & Risk Controlled Stock Pick Alerts - Улправда
Septerna Inc stock hits all-time high at 29.79 USD By Investing.com - Investing.com Nigeria
Septerna (NASDAQ:SEPN) Reaches New 12-Month HighShould You Buy? - MarketBeat
Septerna Inc stock hits all-time high at 29.79 USD - Investing.com
Raymond James Initiates Coverage of Septerna (SEPN) with Strong Buy Recommendation - Nasdaq
Raymond James initiates Septerna stock with Strong Buy rating, $38 target - Investing.com Australia
Raymond James Initiates Coverage on Septerna With Strong Buy Rating, $38 Price Target - marketscreener.com
Raymond James initiates Septerna stock with Strong Buy rating, $38 target By Investing.com - Investing.com India
With Septerna Stock Surging, Have You Considered The Downside? - Trefis
Why Septerna Inc. stock is a must watch in 20252025 Sector Review & Risk Managed Investment Strategies - DonanımHaber
Septerna Inc Azioni (SEPN) Dati Finanziari
Non sono disponibili dati finanziari per Septerna Inc (SEPN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):